Angela Marie Meadows, ARNP Clinical Nurse Specialist - Family Health Medicare: Medicare Enrolled Practice Location: 151 Mary Esther Blvd Ste 403a, Mary Esther, FL 32569 Phone: 850-226-8117 |
News Archive
Women in Britain with breast cancer will soon benefit from a pioneering surgical technique developed by Professor Robert Mansel and his team at Cardiff University, Wales College of Medicine in the UK.
The time that cancer patients nationwide spend when they travel to, wait for and receive inpatient and outpatient treatment costs an estimated $2.3 billion in the first year after diagnosis, according to a study published on Wednesday in the Journal of the National Cancer Institute, the AP/South Florida Sun-Sentinel reports.
Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.
A new study examining whether patients with chronic Hepatitis C virus (HCV) were routinely vaccinated against Hepatitis A virus (HAV) found that vaccination rates were low, even though HAV vaccination is recommended for patients with chronic liver disease.
› Verified 5 days ago